JPRN-UMIN000008632招募中2 期
Phase II study of a Combination of Paclitaxel and 5'-DFUR in Patients with S-1 Failure Unresectable or Recurrent Gastric Cancer - Phase II study of a Combination of Paclitaxel and 5'-DFUR in Patients with S-1 Failure Unresectable or Recurrent Gastric Cancer
Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine0 个研究点目标入组 35 人开始时间: 2012年8月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Drug hypersensitivity. 2) Infection and inflammation. 3) Prior infusion of paclitaxel 4) Peripheral neuropathy 5) Active synchronous malignancy. 6) Brain metastasis. 7) Severe mental disorders. 8) Symptomatic pulmonary fibrosis or interstitial pneumonia. 9) Severe systemic edema. 10) A large amount of pleural effusion or peritoneal fluid. 11) Severe heart disease. 12) Myocardial infarction within six months. 13) DM with insulin injection. 14) Pregnant patient
研究者
相似试验
招募中
不适用
Phase II Study of Paclitaxel in Combination with Carboplatin in Patients With Stage IB-II Cervical Cancer.cervical cancerJPRN-UMIN000012400Department of Obstetrics and Gynecology, Osaka Medical College30
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
2 期
Phase II trial of Combination with Paclitaxel, Carboplatin and Cetuximab (PCE) as a first line treatment in patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckJPRN-UMIN000010507CSPOR-HN 02 executive committee45
进行中（未招募）
1 期
A Phase I/II non-comparative Study of Paclitaxel plus Carboplatin in combination with Vorinostat in patients with advanced, recurrent epithelial ovarian cancerAdvanced, recurrent epithelial ovarian cancerMedDRA version: 9.1Level: LLTClassification code 10033160Term: Ovarian epithelial cancer recurrentEUCTR2006-007013-20-DKOnkologisk afdeling R and the Unit for Experimental Chemotherapy70
已完成
2 期
A phase II study of Paclitaxel combined with Bevacizumab in HER2 negative metastatic Breast Cancermetastatic Breast CancerJPRN-UMIN000008140Kobe Breast Cancer Oncology Group24